Hepatocyte growth factor activator inhibitor-1 has a complex subcellular itinerary

Biochemical Journal

Volumn 413, Issue 2, 2008, Pages 251-259

  Godiksen, Sine ^a   Selzer Plon, Joanna ^a   Pedersen, Esben D K ^a   Abell, Kathrine ^a   Rasmussen, Hanne B ^a   Szabo, Roman ^b   Bugge, Thomas H ^b   Vogel, Lotte K ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Endocytosis; Hepatocyte growth factor activator inhibitor 1 (HAI 1); Lysosomal degradation; Proteolytic release; Transcytosis

Indexed keywords

AMINO ACIDS; BIOACTIVITY; BIOCHEMICAL ENGINEERING; BIOCHEMISTRY; CELL MEMBRANES; CELLS; PEPTIDES; PLASMAS;

APICAL PLASMA MEMBRANE; ENDOSOMES; EPITHELIAL CELLS; HEPATOCYTE GROWTH FACTOR (HGF); INHIBITORY FUNCTION; LYSOSOMES (LYS); MADIN-DARBY CANINE KIDNEY CELLS (MDCK); MAMMARY GLANDS; MEMBRANE-BOUND; PLASMA MEMBRANE (PM); SERINE PROTEASE INHIBITOR (SERPIN); SERINE PROTEASES; TIGHT JUNCTIONS (TJ); TRANSMEMBRANE (TM);

MEMBRANES;

HEPATOCYTE GROWTH FACTOR ACTIVATOR INHIBITOR 1; MATRIPTASE; PROTEINASE; SERINE PROTEINASE INHIBITOR; MEMBRANE PROTEIN; SERINE PROTEINASE; SPINT1 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BASOLATERAL MEMBRANE; BREAST EPITHELIUM; CELL MEMBRANE; CONTROLLED STUDY; ENDOCYTOSIS; ENDOSOME; EPITHELIUM CELL; EXOCYTOSIS; LYSOSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; TRANSCYTOSIS; ANIMAL; BIOLOGICAL MODEL; CELL LINE; DOG; GENE EXPRESSION REGULATION; METABOLISM; MOUSE; PHYSIOLOGY; PROTEIN TRANSPORT; UDDER;

ANIMALS; CELL LINE; CELL MEMBRANE; DOGS; ENDOCYTOSIS; EXOCYTOSIS; GENE EXPRESSION REGULATION; LYSOSOMES; MAMMARY GLANDS, ANIMAL; MEMBRANE GLYCOPROTEINS; MICE; MODELS, BIOLOGICAL; PROTEIN TRANSPORT; SERINE ENDOPEPTIDASES;

EID: 48149114537     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20071496     Document Type: Article

References (41)

1. Tanaka, H., Nagaike, K., Takeda, N., Itoh, H., Kohama, K., Fukushima, T., Miyata, S., Uchiyama, S., Uchinokura, S., Shimomura, T. et al. (2005) Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is reguired for branching morphogenesis in the chorioallantoic placenta. Mol. Cell. Biol. 25, 5687-5698
2. List, K., Haudenschild, C. C., Szabo, R., Chen, W., Wahl, S. M., Swaim, W., Engelholm, L. H., Behrendt, N. and Bugge, T. H. (2002) Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis. Oncogene 21, 3765-3779
3. Szabo, R., Molinolo, A., List, K. and Bugge, T. H. (2007) Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development. Oncogene 26, 1546-1556
4. Carney, T. J., von der Hardt, S., Sonntag, C., Amsterdam, A., Topczewski, J., Hopkins, N. and Hammerschmidt, M. (2006) Inactivation of serine protease Matriptase1a by its inhibitor Hai1 is required for epithelial integrity of the zebrafish epidermis. Development 134, 3461-3471
5. List, K., Szabo, R., Molinolo, A., Sriuranpong, V., Redeye, V., Murdock, T., Burke, B., Nielsen, B. S., Gutkind, S. J. and Bugge, T. H. (2005) Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation. Genes Develop. 19, 1934-1950
6. Shimomura, T., Denda, K., Kitamura, A., Kawaguchi, T., Kito, M., Kondo, J., Kagaya, S., Qin, L., Takata, H., Miyazawa, K. and Kitamura, N. (1997) Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor. J. Biol. Chem. 272, 6370-6376
7. Lin, C. Y., Anders, J., Johnson, M. and Dickson, R. B. (1999) Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. J. Biol. Chem. 274, 18237-18242
8. Fan, B., Wu, T. D., Li, W. and Kirchhofer, D. (2005) Identification of hepatocyte growth factor activator inhibitor-1B as a potential physiological inhibitor of prostasin. J. Biol. Chem. 280, 34513-34520
9. Herter, S., Piper, D. E., Aaron, W., Gabriele, T., Cutler, G., Cao, P., Bhatt, A. S., Choe, Y., Craik, C. S., Walker, N. et al. (2005) Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers. Biochem. J. 390, 125-136
10. Oberst, M., Anders, J., Xie, B., Singh, B., Ossandon, M., Johnson, M., Dickson, R. B. and Lin, C. Y. (2001) Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo. Am. J. Pathol. 158, 1301-1311
11. Oberst, M. D., Singh, B., Ozdemirli, M., Dickson, R. B., Johnson, M. D. and Lin, C. Y. (2003) Characterization of matriptase expression in normal human tissues. J. Histochem. Cytochem. 51, 1017-1025
12. List, K., Szabo, R., Molinolo, A., Nielsen, B. S. and Bugge, T. H. (2006) Delineation of matriptase protein expression by enzymatic gene trapping suggests diverging roles in barrier function, hair formation, and squamous cell carcinogenesis. Am. J. Pathol. 168, 1513-1525
13. Kilpatrick, L. M., Harris, R. L., Owen, K. A., Bass, R., Ghorayeb, C., Bar-Or, A. and Ellis, V. (2006) Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptase. Blood 108, 2616-2623
14. Netzel-Arnett, S., Currie, B. M., Szabo, R., Lin, C. Y., Chen, L. M., Chai, K. X., Antalis, T. M., Bugge, T. H. and List, K. (2006) Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation. J. Biol. Chem. 281, 32941-32945
15. Takeuchi, T., Harris, J. L., Huang, W., Yan, K. W., Coughlin, S. R. and Craik, C. S. (2000) Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J. Biol. Chem. 275, 26333-26342
16. Lee, S. L., Dickson, R. B. and Lin, C. Y. (2000) Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J. Biol. Chem. 275, 36720-36725
17. Mostov, K. E. (2003) Epithelial polarity and morphogenesis. Methods 30, 189-190
18. Mostov, K., Su, T. and ter Beest, M. (2003) Polarized epithelial membrane traffic: conservation and plasticity. Nat. Cell Biol. 5, 287-293
19. Mostov, K. and Zegers, M. (2003) Cell biology: just mix and patch. Nature 422, 267-268
20. Vogel, L. K., Sahkri, S., Sjostrom, H., Noren, O. and Spiess, M. (2002) Secretion of antithrombin is converted from nonpolarized to apical by exchanging its amino terminus for that of apically secreted family members. J. Biol. Chem. 277, 13883-13888
21. Pagano, A. and Spiess, M. (2005) Reconstitution of Rab4-dependent vesicle formation in vitro. Methods Enzymol. 403, 81-92
22. Pagano, A., Crottet, P., Prescianotto-Baschong, C. and Spiess, M. (2004) In vitro formation of recycling vesicles from endosomes requires adaptor protein-1/clathrin and is regulated by Rab4 and the connector rabaptin-5. Mol. Biol. Cell 15, 4990-5000
23. Lee, M. S., Tseng, I. C., Wang, Y., Kiyomiya, K. I., Johnson, M. D., Dickson, R. B. and Lin, C. Y. (2007) Autoactivation of matriptase in vitro: requirement for biomembrane and LDL receptor domain. Am. J. Physiol. Cell Physiol. 293, C95-C105
24. Denda, K., Shimomura, T., Kawaguchi, T., Miyazawa, K. and Kitamura, N. (2002) Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1. J. Biol. Chem. 277, 14053-14059
25. +-ATPase with bafilomycin reduces delivery of internalized molecules from mature multivesicular endosomes to lysosomes in HEp-2 cells. Eur. J. Cell Biol. 69, 343-350
26. Oberst, M. D., Johnson, M. D., Dickson, R. B., Lin, C. Y., Singh, B., Stewart, M., Williams, A., al Nafussi, A., Smyth, J. F., Gabra, H. and Sellar, G. C. (2002) Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters. Clin. Cancer Res. 8, 1101-1107
27. Kataoka, H., Suganuma, T., Shimomura, T., Itoh, H., Kitamura, N., Nabeshima, K. and Koono, M. (1999) Distribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues. Cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissues. J. Histochem. Cytochem. 47, 673-682
28. Maxfield, F. R. and Mcgraw, T. E. (2004) Endocytic recycling. Nat. Rev. Mol. Cell Biol. 5, 121-132
29. Denda, K., Shimomura, T., Kawaguchi, T., Miyazawa, K. and Kitamura, N. (2002) Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1. J. Biol. Chem. 277, 14053-14059
30. Parry, S., Hanisch, F. G., Leir, S. H., Sutton-Smith, M., Morris, H. R., Dell, A. and Harris, A. (2006) N-Glycosylation of the MUC1 mucin in epithelial cells and secretions. Glycobiology 16, 623-634
31. Kato, K., Jeanneau, C., Tarp, M. A., Benet-Pages, A., Lorenz-Depiereux, B., Bennett, E. P., Mandel, U., Strom, T. M. and Clausen, H. (2006) Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation. J. Biol. Chem. 281, 18370-18377
32. Leuenberger, B., Hahn, D., Pischitzis, A., Hansen, M. K. and Sterchi, E. E. (2003) Human meprin beta: O-linked glycans in the intervening region of the type I membrane protein protect the C-terminal region from proteolytic cleavage and diminish its secretion. Biochem. J. 369, 659-665
33. Shimomura, T., Denda, K., Kawaguchi, T., Matsumoto, K., Miyazawa, K. and Kitamura, N. (1999) Multiple sites of proteolytic cleavage to release soluble forms of hepatocyte growth factor activator inhibitor type 1 from a transmembrane form. J. Biochem. (Tokyo) 126, 821-828
34. Julenius, K., Molgaard, A., Gupta, R. and Brunak, S. (2005) Prediction, conservation analysis, and structural characterization of mammalian mucin-type O-glycosylation sites. Glycobiology 15, 153-164
35. Vogel, L. K., Suske, G., Beato, M., Noren, O. and Sjostrom, H. (1993) Uteroglobin, an apically secreted protein of the uterine epithelium, is secreted non-polarized from MDCK cells and mainly basolaterally from Caco-2 cells. FEBS Lett. 330, 293-296
36. Lerdrup, M., Hommelgaard, A. M., Grandal, M. and van Deurs, B. (2006) Geldanamycin stimulates internalization of ErbB2 in a proteasome-dependent way. J. Cell Sci. 119, 85-95
37. Oberst, M. D., Williams, C. A., Dickson, R. B., Johnson, M. D. and Lin, C. Y. (2003) The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor. J. Biol. Chem. 278, 26773-26779
38. Oberst, M. D., Chen, L. Y., Kiyomiya, K., Williams, C. A., Lee, M. S., Johnson, M. D., Dickson, R. B. and Lin, C. Y. (2005) HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease. Am. J. Physiol. Cell Physiol. 289, C462-C470
39. Reference deleted
40. Verghese, G. M., Gutknecht, M. F. and Caughey, G. H. (2006) Prostasin regulates epithelial monolayer function: cell-specific Gpld1-mediated secretion and functional role for GPI anchor. Am. J. Physiol. Cell Physiol. 291, C1258-C1270
41. Tsuzuki, S., Murai, N., Miyake, Y., Inouye, K., Hirayasu, H., Iwanaga, T. and Fushiki, T. (2005) Evidence for the occurrence of membrane-type serine protease 1/matriptase on the basolateral sides of enterocytes. Biochem. J. 388, 679-687